Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients (age ≥18 years)
Diagnosis of severe eosinophilic asthma requiring stable treatment of high doses of inhaled corticosteroids and a long-acting agonist β2 ± additional asthma controller.
Patients with at least 12-month data available before index date (starting benralizumab treatment)
Patients with at least 3-month electronic medical records data available from first benralizumab dose ("index date")
Informed consent signed.
You may not be if
Patients who received benralizumab in a clinicaltrial, during the observation period.